Evidence map›Paper›PMID 42757711›Full record

ReviewThe Cochrane database of systematic reviews2026

Monitoring strategies in adults eligible for pharmacological lipid-lowering therapy.

Kamyar Shokraee, Brenda Bongaerts, Petek Eylul Taneri, Camila Micaela Escobar Liquitay, Siavosh Olfati, Ana-Mihaela Zorger, Nicole Skoetz, Juan Va Franco

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Cochrane database of systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kamyar ShokraeeCochrane Evidence Synthesis Germany/UK, Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Brenda BongaertsCochrane Evidence Synthesis Germany/UK, Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Petek Eylul TaneriCochrane Evidence Synthesis Germany/UK, Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Camila Micaela Escobar LiquitayCochrane Evidence Synthesis Unit Iberoamérica, Research Department, Universidad del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Siavosh OlfatiCochrane Evidence Synthesis Unit Germany/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Ana-Mihaela ZorgerCochrane Evidence Synthesis Unit Germany/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Nicole SkoetzCochrane Evidence Synthesis Unit Germany/UK, Institute of Public Health, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Juan Va FrancoCochrane Evidence Synthesis Germany/UK, Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.ORCID https://orcid.org/0000-0003-0411-899X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis is a protocol for a Cochrane review (intervention). The objectives are as follows: To assess the effects of different laboratory monitoring strategies for treatment efficacy (lipid levels) and treatment safety (hepatic, muscular, and renal parameters) in adults eligible for or receiving pharmacological lipid-lowering therapy for primary and/or secondary prevention of cardiovascular disease, including whether such monitoring is performed and the frequency or timing with which it is repeated.

Indexed as

Cardiovascular DiseasesDrug MonitoringHypolipidemic AgentsAdultHumansLipidsRandomized Controlled Trials as TopicHypolipidemic AgentsLipids

Identifiers

PMID42757711
PMCPMC13587225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.